Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Hiroaki Kanzaki, Yujin Hoshida

Journal title: Clinical and Molecular Hepatology

Journal number: 31

Journal publisher: Korean Association for the Study of the Liver

Published year: 2025

Published pages: 308-310

DOI identifier: 10.3350/cmh.2024.0726

ISSN: 2287-2728